FDA - Food and Drug Administration
US FDA says it is investigating another cyclosporiasis outbreak
The agency's announcement on Wednesday adds to the growing number of cyclosporiasis cases reported across the US Midwest, including Michigan and four other states.
FDA reverses lettuce warning: Taylor Farms cyclospora test was a false positive
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era
Israel expected to recognize Russia’s Sputnik V coronavirus vaccine
Travelers would be required to take a PCR and an antibody test on entry to the country.
FDA experts recommend vaccines for young children
Half of Israeli parents say they will give their children coronavirus vaccines.
US FDA clears Moderna and J&J boosters
The decision paves the way for millions more people in the US to get the additional protection with the highly contagious Delta variant of the virus causing breakthrough infections.
Generic, cancer-killing Israeli drug approved for marketing by FDA
The drug, and the company that makes it, is located in Jerusalem and was developed by Prof. Yechezkel Barenholz.
FDA to allow mix and match of COVID-19 booster vaccines- NYT
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said.
COVID-19: FDA advisers back Moderna booster shots for older and high-risk people
The CDC will make specific recommendations on who should get the booster shots.
COVID: mRNA booster dose generates stronger antibody response after J&J shot
New data shows that those who get an mRNA jab after the Johnson & Johnson vaccine will have a stronger antibody response.
Israel's DreaMed gets FDA clearance for diabetes solution
Israeli company DreaMed Diabetes AI developed Advisor Pro, a decision support system to assist healthcare providers in the management of diabetes patients with insulin pumps or injections.
FDA decision to limit COVID booster shots didn't satisfy anyone - opinion
The FDA approved the COVID-19 booster shot only for high-risk patients and people over 65, which is not the answer Pfizer, the US and Israel wanted to hear.
US eyes IDF soldiers' data for Pfizer COVID-19 booster safety
US health officials are hoping data on Israeli military personnel can help clarify the risk of heart muscle inflammation in younger people who have received Pfizer/BioNTech COVID-19 booster shots.
